About Vascular Perfusion
Vascular Perfusion is a company based in San Antonio (United States) founded in 2016 by Tom DeBrooke.. Vascular Perfusion has raised $151.67 million across 6 funding rounds. Vascular Perfusion offers products and services including VP.S ENCORE®. Vascular Perfusion operates in a competitive market with competitors including TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and ADVITOS, among others.
- Headquarter San Antonio, United States
- Founders Tom DeBrooke
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vascular Perfusion Solutions, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$151.67 M (USD)
in 6 rounds
-
Latest Funding Round
$147.02 M (USD), Series D
May 16, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vascular Perfusion
Vascular Perfusion offers a comprehensive portfolio of products and services, including VP.S ENCORE®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medical device for preserving organs during transplantation processes.
Unlock access to complete
Funding Insights of Vascular Perfusion
Vascular Perfusion has successfully raised a total of $151.67M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $147.02 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $147.0M
-
First Round
First Round
(18 Jun 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series D - Vascular Perfusion | Valuation |
investors |
|
| May, 2023 | Amount | Seed - Vascular Perfusion | Valuation |
investors |
|
| May, 2022 | Amount | Seed - Vascular Perfusion | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Vascular Perfusion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vascular Perfusion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vascular Perfusion Comparisons
Competitors of Vascular Perfusion
Vascular Perfusion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and ADVITOS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of organ transplantation technology
|
|
| domain | founded_year | HQ Location |
Warm storage and transport systems for harvested organs are provided.
|
|
| domain | founded_year | HQ Location |
Organ preservation and transport systems are developed for transplants.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Multi-organ support systems for liver, lung, and kidney are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vascular Perfusion
Frequently Asked Questions about Vascular Perfusion
When was Vascular Perfusion founded?
Vascular Perfusion was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is Vascular Perfusion located?
Vascular Perfusion is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Who is the current CEO of Vascular Perfusion?
Tom DeBrooke is the current CEO of Vascular Perfusion. They have also founded this company.
Is Vascular Perfusion a funded company?
Vascular Perfusion is a funded company, having raised a total of $151.67M across 6 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jun 18, 2019.
What does Vascular Perfusion do?
Vascular Perfusion was founded in 2016 in San Antonio, United States, within the medical device sector focused on organ transplantation. Operations center on the development of the VP.S ENCORE device, which aims to prolong organ viability outside the body. This addresses rejection issues caused by transportation delays, surpassing the standard ice-cooling preservation method. The companys efforts target improvements in transplant therapy accessibility.
Who are the top competitors of Vascular Perfusion?
Vascular Perfusion's top competitors include TransMedics, OrganOx and ADVITOS.
What products or services does Vascular Perfusion offer?
Vascular Perfusion offers VP.S ENCORE®.